购物车
- 全部删除
- 您的购物车当前为空
UNC 669是一种有效且特异性的 MBT(恶性脑瘤)抑制剂,是甲基赖氨酸结合结构域的配体,是L3MBTL1和L3MBTL3的抑制剂,IC50分别为 4.2 和 3.1 uM。
为众多的药物研发团队赋能,
让新药发现更简单!
UNC 669是一种有效且特异性的 MBT(恶性脑瘤)抑制剂,是甲基赖氨酸结合结构域的配体,是L3MBTL1和L3MBTL3的抑制剂,IC50分别为 4.2 和 3.1 uM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 116 | 现货 | |
5 mg | ¥ 176 | 现货 | |
10 mg | ¥ 296 | 现货 | |
25 mg | ¥ 479 | 现货 | |
50 mg | ¥ 682 | 现货 | |
100 mg | ¥ 1,180 | 现货 | |
200 mg | ¥ 1,760 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 202 | 现货 |
产品描述 | UNC 669 is an effective and specific MBT (malignant brain tumor) inhibitor with IC50 of 4.2/3.1 uM for L3MBTL1/3. |
靶点活性 | L3MBTL1:4.2 μM, L3MBTL3:3.1 μM |
激酶实验 | In vitro Enzyme Assays.: All in vitro enzyme assays are done at Upstate Biotechnology with the exception of InsR and IGF-1R. To determine the IC50 of TAE684 against InsR and IGF-1R a homogeneous time-resolved fluorescence assay is performed. ATP (10 mM) and 20 mg/ml biotinylated PolyEY (Glu, Tyr 4:1) are combined with 50 nL of serial dilutions of TAE684 (10-500 nM) and 4 ng of InsR enzyme in the presence of the kinase reaction buffer (20 mM Tris譎Cl, pH 7.5/10 mM MgCl2/3 mM MnCl2/1 mM DTT/10 mM NaVO4/0.1 mg/ml of BSA). Assays are incubated for 1 hour at ambient temperature. Reactions are terminated by adding 10 mL of the detection solution containing 50 mM EDTA, 500 mM KF, 0.5 mg/ml of BSA, 5 mg/mL Eu3+ cryptate-labeled anti-phosphotyrosine antibody Mab PT66-K, and 5 mg/mL Streptavidin-XLent. The reaction is incubated for half an hour, and fluorescence signals are read on Analyst GT. |
别名 | UNC-669, UNC669 |
分子量 | 338.24 |
分子式 | C15H20BrN3O |
CAS No. | 1314241-44-5 |
Smiles | Brc1cncc(c1)C(=O)N1CCC(CC1)N1CCCC1 |
密度 | 1.424 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 9 mg/mL (26.6 mM) Ethanol: 63 mg/mL (186.3 mM) H2O: < 1 mg/mL (insoluble or slightly soluble) | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容